(b) Bevacizumab is an antibody that exhibits anti-cancer activity by binding to vascular endothelial growth factor (VEGF

Business, Finance, Economics, Accounting, Operations Management, Computer Science, Electrical Engineering, Mechanical Engineering, Civil Engineering, Chemical Engineering, Algebra, Precalculus, Statistics and Probabilty, Advanced Math, Physics, Chemistry, Biology, Nursing, Psychology, Certifications, Tests, Prep, and more.
Post Reply
answerhappygod
Site Admin
Posts: 899603
Joined: Mon Aug 02, 2021 8:13 am

(b) Bevacizumab is an antibody that exhibits anti-cancer activity by binding to vascular endothelial growth factor (VEGF

Post by answerhappygod »

B Bevacizumab Is An Antibody That Exhibits Anti Cancer Activity By Binding To Vascular Endothelial Growth Factor Vegf 1
B Bevacizumab Is An Antibody That Exhibits Anti Cancer Activity By Binding To Vascular Endothelial Growth Factor Vegf 1 (30.3 KiB) Viewed 46 times
(b) Bevacizumab is an antibody that exhibits anti-cancer activity by binding to vascular endothelial growth factor (VEGF). What are the main constraints in formulating this therapeutic biomolecule for injection? When answering, consider the chemical, physical and biological properties of antibodies and how these might be affected by the practical requirements for injectable formulations. [12 marks; word limit = 300]
Join a community of subject matter experts. Register for FREE to view solutions, replies, and use search function. Request answer by replying!
Top
Post Reply

Return to “Archived Questions & Answers”